Alembic Ltd.
BSE: 506235 | Sector: Health care |
NSE: ALEMBICLTD | ISIN Code: INE426A01027 |
BSE 12:30 | 04 Jul | 71.50 |
9.00 (14.40%) |
OPEN
62.80 |
HIGH
71.95 |
LOW
62.80 |
NSE 12:19 | 04 Jul | 71.00 |
8.40 (13.42%) |
OPEN
62.90 |
HIGH
71.85 |
LOW
62.90 |
OPEN | 62.80 |
PREVIOUS CLOSE | 62.50 |
VOLUME | 56208 |
52-Week high | 139.35 |
52-Week low | 56.50 |
P/E | 21.41 |
Mkt Cap.(Rs cr) | 1,836 |
Buy Price | 71.20 |
Buy Qty | 50.00 |
Sell Price | 71.40 |
Sell Qty | 10.00 |
Alembic Ltd. (ALEMBICLTD) - Net Profit
Net Profit
COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
Aurobindo Pharma | 523.80 | 1.25 | 0.24 | 3112.91 |
Cipla | 935.00 | -15.10 | -1.59 | 2468.28 |
Dr Reddy's Labs | 4362.80 | -21.55 | -0.49 | 2186.40 |
Sun Pharma.Inds. | 828.50 | 1.80 | 0.22 | 2139.70 |
Divi's Lab. | 3639.25 | 4.45 | 0.12 | 1954.72 |
Glaxosmi. Pharma | 1529.70 | 26.35 | 1.75 | 1690.53 |
Alkem Lab | 3004.85 | -15.40 | -0.51 | 1685.08 |
Glenmark Pharma. | 384.85 | -9.15 | -2.32 | 1649.45 |
Zydus Lifesci. | 362.40 | 0.30 | 0.08 | 1476.20 |
Lupin | 626.35 | -2.20 | -0.35 | 1258.62 |
Alembic Pharma | 732.55 | 3.20 | 0.44 | 1175.39 |
Ipca Labs. | 911.60 | -1.30 | -0.14 | 1140.77 |
Torrent Pharma. | 2919.50 | 4.50 | 0.15 | 1137.85 |
Gland Pharma | 2590.40 | -65.50 | -2.47 | 997.01 |
Sanofi India | 6426.40 | 58.65 | 0.92 | 944.40 |
Laurus Labs | 465.75 | -0.50 | -0.11 | 750.09 |
Abbott India | 19020.00 | -61.95 | -0.32 | 690.69 |
Ajanta Pharma | 1234.50 | -30.15 | -2.38 | 675.64 |
Wockhardt | 209.75 | 2.05 | 0.99 | 593.29 |
Granules India | 279.80 | 1.30 | 0.47 | 552.78 |
Quick Links for Alembic:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices